Athira Pharma to Participate in Jefferies London Healthcare Conference
08 11월 2023 - 9:00PM
Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage
biopharmaceutical company focused on developing small molecules to
restore neuronal health and slow neurodegeneration, today announced
that Company management will participate at the Jefferies London
Healthcare Conference, taking place from November 14-16, 2023, in
London. Details are as follows:
Jefferies London Healthcare ConferenceFormat:
Fireside Chat Date and Time: Thursday, November 16, 2023, from 1:30
pm - 1:55 pm GMT Location: Waldorf Hilton, London
A live webcast of the Fireside Chat can be accessed from the
Investors section of the Athira website at
https://investors.athira.com/news-and-events/events-and-presentations-investor.
An archived replay will be available for at least 30 days following
the event.
About Athira Pharma, Inc.Athira Pharma, Inc.,
headquartered in the Seattle, Washington area, is a late
clinical-stage biopharmaceutical company focused on developing
small molecules to restore neuronal health and slow
neurodegeneration. Athira aims to alter the course of neurological
disease by advancing its pipeline of therapeutic candidates that
modulate the neurotrophic HGF system. For more information,
visit www.athira.com. You can also follow Athira
on Facebook, LinkedIn and @athirapharma on X,
formerly known as Twitter, and Instagram.
Investor & Media Contact:
Julie RathbunAthira
PharmaJulie.rathbun@athira.com206-769-9219
Athira Pharma (NASDAQ:ATHA)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Athira Pharma (NASDAQ:ATHA)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024